.jpg "Medtech at the Cantiere Futuro center on 28 September in Milan")
L 'union between medicine and technology has opened the doors to a new era of science, also focused on data analysis, predictive diagnostics and gene therapy. Thanks to scientific research and technology transfer, innovative solutions for the treatment of diseases now considered invincible and new therapies to accelerate traditional treatment processes are studied with the ideas brought from the laboratory to the market. A frontier crossed every day thanks to the work of researchers.
How much is Medtech worth in the world
The anti-Covid mRNA vaccines, created thanks to years of research by two elderly biotech startups, such as Moderna and Biontech, have demonstrated the full power of technology applied in the medical field. But they are by no means the only stars in the industry. A Mediobanca research has lined up numbers to understand the economic power of Medtech: in 2021 the sector had a worldwide turnover of 535.6 billion euros and forecasts for 2024 are of 632.6 billion in revenues. Medtech is already worth 5.5% of world health spending and develops investments in research for 33 billion euros.In Europe, Medtech boasts a turnover of 155 billion euros and according to Mediobanca estimates 12% moves to Italy: "In 2020 the aggregate turnover of the 227 main Italian Medtech companies was equal to 18.6 billion euros, of which 8.9 billion from production companies and 9.7 billion from commercial ones ”, reads the analysis by Piazzetta Cuccia. "In the two-year period 2018-2020 the Italian Medtech achieved an average annual growth of 7%, with the foreign turnover (+ 9%) that ran more than the national one (+ 5.7%)", with the prospects also for 2022 underway which are "very positive".